Fathi AT, Arowojolu O, SwinnenI, Sato T, Rajkhowa T, Small D, Marmsater F,Robinson JE, Gross SD, Martinson M, Allen S,Kallan N, and Levis M. PIM1: A potential therapeutic target forFLT3/ITD AML. Submitted for publication.
Fathi AT, GrantS, Karp JE. Exploiting cellular pathways to develop new treatment strategiesfor AML. Cancer Treatment Reviews, 2010,Jan 5.
Fathi AT,Karp JE. New Agents in AML: Beyond Cytarabine and Anthracyclines. Current Oncology Reports (2009)11:346-352.
Fathi AT, LevisM. Lestaurtinib: a multi-targeted FLT3 inhibitor. Expert Rev. Hematol. February 2009, 2(1):17-26.
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.